IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Postal Ballot Notice - Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliance Certificate For The Period Ended 31St March 2023
Pursuant to Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith compliance certificate for the period ended 31st March 2023. IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith a certificate received from M/s. Alankit Assignment Limited, Registrar and Share Transfer Agent of the Company in compliance with the requirements of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March 2023. IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
In continuation to our Press release dated 05.04.2023 and with reference to your mail dated 06.04.2023 / 07.04.2023, we are attaching herewith same Press release titled 'IOL Chemicals and Pharmaceuticals appoints Vikas Vij as CEO' along with covering letter addressed to the BSE limited. IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
IOL Chemicals and Pharmaceuticals appoints Vikas Vij as CEO IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Board Meeting Outcome for Outcome Of The Board Meeting Held On 3Rd April 2023
Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on today i.e. 3rd April 2023 has inter alia has: 1. Approved the change of the designation of Mr Vikas Gupta from Executive Director to Joint Managing Director of the Company. 2. Appointed Mr Abhiraj Gupta as Additional Director in the category of Executive Director with effect from 3rd April 2023. 3. Appointed Mr Vikas Vij as Chief Executive Officer (CEO) of the Company with effect from 3rd April 2023. 4. Took note of the resignation of Dr Sanjay Chaturvedi (DIN: 08927689) from the position of Executive Director & CEO of the Company and accorded their approval to relieve Dr. Sanjay Chaturvedi from the closure of business hours on 3rd April 2023. 5. Took note of the completion of Unit 9, a multi-product manufacturing facility at Barnala Plant site. IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Closure of Trading Window
Pursuant to the requirements of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's 'Code of Conduct to Regulate, Monitor and Reporting of Trading by Designated Persons' the Trading Window for dealing in the securities of the Company, shall remain closed for all the designated persons and their immediate relatives from 1st April 2023 till the expiry of 48 hours after the declaration of financial results for quarter and year ended 31st March 2023 are made public. During the closure of Trading Window, Insiders are also advised not to deal in the shares of the Company. The date of the Board Meeting in which the financial results would be approved will be advised in due course. IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Notice published in newspapers regarding loss of Share Certificates IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of lost share certificate IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mayadevi Polycot Ltd